Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

KRX:185750 Revenue

Chong Kun Dang Pharmaceutical had revenue of 400.96B KRW in the quarter ending March 31, 2025, with 10.91% growth. This brings the company's revenue in the last twelve months to 1.63T, down -2.39% year-over-year. In the year 2024, Chong Kun Dang Pharmaceutical had annual revenue of 1.59T, down -4.97%.

• Revenue (ttm): 1,625.88B
• Revenue Growth: -2.39%
• P/S Ratio: 0.69
• Revenue / Employee: 714.36M
• Employees: 2,276
• Market Cap: 1,126.55B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1,586.43B	-82.97B	-4.97%
Dec 31, 2023	1,669.40B	181.06B	12.17%
Dec 31, 2022	1,488.34B	144.79B	10.78%
Dec 31, 2021	1,343.56B	40.55B	3.11%
Dec 31, 2020	1,303.01B	223.67B	20.72%